Table 2 |
||||
|
Correlation between MMP-13 expression and clinicopathological parameters of chondrosarcoma patients. |
||||
|
Parameter |
No. of patients |
MMP-13 immunostaining |
P-value |
|
|
|
||||
|
MMP-13 (-ve) (n = 3) % |
MMP-13 (+ve) (n = 8) % |
|||
|
|
||||
|
Age |
||||
|
>60 |
6 |
2 (33.3%) |
4(66.7%) |
|
|
≤ 60 |
5 |
1 (20%) |
4 (80%) |
NS |
|
Sex |
||||
|
Male |
7 |
2 (28.6%) |
5(71.4%) |
|
|
Female |
4 |
1 (25%) |
3(75%) |
NS |
|
Site |
||||
|
Mandible |
8 |
2 (25%) |
6(75%) |
|
|
Maxilla |
3 |
1 (33.3%) |
2(66.7%) |
NS |
|
Mitosis |
||||
|
0 |
3 |
3 (100%) |
0(0%) |
|
|
1 |
4 |
0(0%) |
4(100%) |
|
|
2 |
2 |
0(0%) |
2(100%) |
*S |
|
3 |
2 |
0 (0%) |
2 (100%) |
|
|
Necrosis |
||||
|
o |
5 |
3 (60%) |
2 (40%) |
|
|
1 |
4 |
0 (0%) |
4 (100%) |
*S |
|
2 |
2 |
0 (0%) |
2 (100%) |
|
|
Grades |
||||
|
G-I |
4 |
3 (75%) |
1 (25%) |
|
|
G-II |
5 |
0 (0%) |
5 (100%) |
*S |
|
G-III |
2 |
0 (0%) |
2 (100%) |
|
|
Recurrence |
||||
|
+ |
3 |
0(0%) |
3 (100%) |
|
|
- |
8 |
3 (37.5%) |
5 (62.5%) |
NS |
|
|
||||
|
P ≤ 0.05 means significant difference *S = Signficant NS = Not significant Necrosis Non = "0", <50% = "1", ≥ 50% = "2". Mitosis 0–9/10HPF = "1", 10–19/10HPF = "2", ≥ 20/10HPF = "3" |
||||
|
Zyada and Shamaa Diagnostic Pathology 2008 3:26 doi:10.1186/1746-1596-3-26 |
||||
